---
schema_version: "secwatch.filing_event.v1"
accession: "0000896264-25-000178"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2025-07-22T23:59:59+00:00"
generated_at: "2026-05-18T04:51:15.524482+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# USANA Q2: net sales +11% to $236M, net earnings -7%; FY guidance reiterated

## Summary
- Net sales $236M (+11% YoY); net earnings $9.7M (-7% YoY); diluted EPS $0.52 (-4% YoY).
- Adjusted diluted EPS $0.74 (+36% YoY); adjusted EBITDA $30.5M (+13% YoY).
- Direct selling Active Customers fell 11% YoY to 418k; Hiya subscribers 200.4k.
- Repurchased 528k shares for $15M; ended quarter debt-free with $151M cash.
- Reiterated FY2025 outlook: net sales $920M-$1.0B, adjusted EPS $2.35-$3.00.

## SEC filing metadata
- accession: 0000896264-25-000178
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2025-07-22T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000089626425000178/0000896264-25-000178-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000089626425000178/usna-20250722.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000896264-25-000178
- JSON: https://secwatch.observer/filing/0000896264-25-000178.json
- Plain text: https://secwatch.observer/filing/0000896264-25-000178.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.